UPDATE 3-Abbott's Acculink stent trial met goals-FDA staff | Reuters
Links shared publicly online about this topic.
- 557total visits
UPDATE 3-Abbott's Acculink stent trial met goals-FDA staff | Reuters
* Device already approved for at-risk surgical patients * Abbott seeks U.S. OK for patients at less risk * Company: sales modest now, seen growing over time * FDA panel to consider wider use of stent
View full resource at reuters.com
Tags: Circulation, FDA
Most Recently Shared on January 24, 2011 at 7:37 pm By:
What's next for $ABT stent for clogged neck arteries? #FDA panel meets Wednesday: http://link.reuters.com/man67r
Advertisement
